Tag: Orphan Drugs
Zydus granted orphan drug designation by USFDA for ZYIL1 in treatment...
Orphan drug designation by USFDA for ZYIL1, provides eligibility for certain development incentives, including tax credits for qualified clinical testing, prescription drug user fee exemptions and seven-year marketing exclusivity